Genetic Technologies (AU:GTG) has released an update.
Genetic Technologies Limited has announced an extension for its Entitlement Offer Prospectus until December 2, 2024, providing investors more time to consider participation. This non-renounceable pro-rata issue update aims to enhance investor engagement and potentially bolster the company’s capital base.
For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
